Although the STAT3 somatic mutation carrier frequency was similar between MS patients and unaffected controls, we found a modest (p = 0.03, pcorr = 0.12) increase in the number of participants with multiple mutations. The gene discussed is STAT3; the disease is myeloid sarcoma.